StockData
Elevance Health, Inc. logo

Elevance Health, Inc.

ELVNYSEHospital & Medical Service PlansFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Oct 21, 2026Score 15/3014% below fair value
$413.60−6.47 (-1.54%)

Close on Nov 2, 2026Market cap $89.70BP/E 18.4Yield –

Elevance Health Total Carelon by Quarter

Total Carelon — Segment Benefit Expense (ASU 2023-07) ($M)

QuarterlyAnnual

Elevance Health Total Carelon: $6,521M in Q3 2026, up 2.7% from a year earlier.

Latest, Q3 2026
6,521
Period ended Sep 30, 2026
Change on a year earlier
+2.7%
6,349 in Q3 2025
History
11 quarters
Since Q1 2024
Sources
8
Documents cited below

Where the Q3 2026 figure comes from

“|| Benefit expense | $ | 37,625 | $ | — | $ | 6,521 | $ | 6,521 | $ | 6 | $ | ( 6,373 ) | $ | 37,779”

Source: 10-Q (2026-10-21) ↗

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedTotal Carelon — Segment Benefit Expense (ASU 2023-07) ($M)Year on yearSource
Q3 2026Sep 30, 20266,521+2.7%10-Q (2026-10-21) ↗
Q2 2026Jun 30, 20266,743+7.2%10-Q (2026-07-15) ↗
Q1 2026Mar 31, 20266,085+14.4%10-Q (2026-04-22) ↗
Q4 2025Dec 31, 20256,325+59.0%Derived Q4 = FY2025 (10-K (FY2025, 2026-02-06)) − 9M2025 (10-Q (2026-10-21)) ↗
Q3 2025Sep 30, 20256,349+68.5%10-Q (2026-10-21) ↗
Q2 2025Jun 30, 20256,290+73.2%10-Q (2026-07-15) ↗
Q1 2025Mar 31, 20255,319+76.7%10-Q (2026-04-22) ↗
Q4 2024Dec 31, 20243,979–Derived Q4 = FY2024 (10-K (FY2025, 2026-02-06)) − 9M2024 (10-Q (2025-10-21)) ↗
Q3 2024Sep 30, 20243,767–10-Q (2025-10-21) ↗
Q2 2024Jun 30, 20243,632–10-Q (2025-07-17) ↗
Q1 2024Mar 31, 20243,010–10-Q (2025-04-22) ↗

Cite this data

StockData. (2026). Elevance Health Total Carelon ($M), quarterly Q1 2024–Q3 2026 [Data set]. Compiled from Elevance Health SEC filings and investor materials. https://stockdatahq.com/stocks/elv/kpis/seg-carelon-total-benefit-expense

See every metric in the Elevance Health KPI table. Data updated Oct 28, 2026.